Audio Interview

Towards developing a universal influenza vaccine

Published on April 1, 2018   23 min

Other Talks in the Therapeutic Area: Vaccines

0:00
Interviewer: Professor Palese, thank you for sparing the time today. I very much enjoyed your talk in the collection on influenza. The subject today is Universal Influenza Vaccines. As I understand it, as one of your research projects, you are committed to attempting to develop a universal influenza vaccine. Is that right? Prof. Palese: Correct. Absolutely. So, my name is Peter Palese. I'm Professor and Chair of Microbiology at the Icahn School of Medicine at Mount Sinai, this is in Manhattan, New York, and we are working on the development of new and improved influenza virus vaccines. As you are probably aware of, influenza virus vaccines have to be administered every year, and the reason is that the virus, the influenza viruses, change, and every year we have to deal with new slightly different variants, and therefore, we have to administer influenza virus vaccines on an annual basis. To avoid that and to make vaccines which would last 20 years or a lifetime, we and others are trying to develop universal influenza virus vaccines.
Hide

Towards developing a universal influenza vaccine

Embed in course/own notes